Sponsor Pipeline

Guangzhou JOYO Pharma Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
4
Recruiting
2
Phase 3
6
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2/3
1
Phase 2
3
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07154368 JYP0322 Versus Platinum Based Doublet Chemotherapy in ROS1 Positive Patients Previously… Non Small Cell Lung Cancer Not Yet Recruiting
Phase 2/3
NCT06125327 SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis… Idiopathic Pulmonary Fibrosis Recruiting
Phase 2
NCT06697535 A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute… Neuromyelitis Optica Spectrum Disorders Recruiting
NCT06895031 Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in… Solid Tumor Recruiting
NCT06158490 A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis Moderate-to-severe Atopic Dermatitis Enrolling by Invitation
Phase 1
NCT06128148 Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors Protein Kinase Inhibitors Recruiting
Disease Areas
Lung Cancer (3) Non-Small Cell Lung Cancer (NSCLC) (2) Idiopathic Pulmonary Fibrosis (1) Atopic Dermatitis (1) Colorectal Cancer (1) Pancreatic Cancer (1)
Get alerts when Guangzhou JOYO Pharma Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free